Qualigen Therapeutics Inc (QLGN) Company Profile & Statistics

Qualigen Therapeutics Inc
QLGN
(Nasdaq - US)
Closed
0.31
+0.00 (-0.42%)
in:usd•As of: Apr 19, 2024 15:32 UTC -4
Open
0.33
High
0.33
Low
0.31

About Qualigen Therapeutics Inc

CEO

Michael S. Poirier

Headquarters

5857 owens avenue, suite 300

carlsbad, ca 92008, united states

Auditor

BAKER TILLY US, LLP

Employees

Share Holders

287

Website

www.qualigeninc.com

Industry

pharmaceuticals other

Sector

health technology

Company Overview

Qualigen Therapeutics Inc. is a biotechnology company. It is focused on developing products for the treatment and testing of cancer and infectious diseases. The company's product pipeline consist AS1411 and Gold Nanoparticle ALAN, RAS-F3 and STARS(TM) blood cleansing system, which are in clinical stage. Qualigen Therapeutics Inc., formerly known as Ritter Pharmaceuticals Inc., is based in CA, United States.

Qualigen Therapeutics Inc Statistics

Valuation Measures

Market Capitalization ²	1.96M
Enterprise Value	2.86M
Enterprise Value/EBITDA (ttm)	-0.43
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	N/A
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	14.71%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	-113.06%
Return on Equity (ttm)	-841.99%
Return on Invested Capital (ttm)	102.17%
Return on Assets (ttm)	-137.02%

Income Statement

Revenue (ttm)	3.23M
Revenue Per Share (ttm)	0.51
Gross Profit (ttm)	952.80K
EBITDA (ttm)³	-6.60M
Net Income Avi to Common (ttm)	-13.42M
Diluted EPS (ttm)	N/A

Share Statistics

Beta (5Y Monthly)	-0.81
52-Week Change	-68.05%
S&P500 52-Week Change	19.56%
S&P500 Member	No
Stock Optionable	No
Total Shares Outstanding ¹	6.31M
Dividend Yield	0.00%
Float ⁴	5.94M
% Held by Insiders	5.80%
% Held by Institutions	3.18%

Balance Sheet

Total Cash (mrq)	401.80K
Total Cash Per Share (mrq)	0.06
Total Debt (mrq)	1.30M
Total Debt/Equity (mrq)	-61.76%
Current Ratio (mrq)	0.28%
Quick Ratio (mrq)	0.28%
Book Value Per Share (mrq)	-0.39

Cash Flow

Operating Cash Flow Per Share (ytd)	-2.03
Free Cash Flow (ytd)	-10.30M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Qualigen Therapeutics Inc

Trade With A Regulated Broker